Stephen Kanes

Insider Reports History

Location
Cheshire, United Kingdom
Signature
/s/ Gregory Weinhoff, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Kanes:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Medical Officer Common Stock 13,471 $259,586 $19.27 19 Oct 2021 Direct
Centessa Pharmaceuticals plc Chief Medical Officer Share Option (right to buy) 500,000 03 Feb 2025 Direct

Insider Reports Filed by Stephen Kanes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTA Centessa Pharmaceuticals plc 03 Feb 2025 1 $0 4 Chief Medical Officer 04 Feb 2025, 16:57
CNTA Centessa Pharmaceuticals plc 06 Jan 2025 0 $0 3 Chief Medical Officer 16 Jan 2025, 16:16
SAGE Sage Therapeutics, Inc. 19 Oct 2021 2 -$45,125 4 Chief Medical Officer 21 Oct 2021, 16:02
SAGE Sage Therapeutics, Inc. 15 Jun 2021 2 -$58,859 4 Chief Medical Officer 17 Jun 2021, 09:12